Literature DB >> 33787464

Exploring the challenges in accessing care and support for cancer survivors in Australia during COVID-19.

Cindy Davis1, Tamara Cadet2, Karina Rune1, Patricia Wilson3, Janneka Banks3.   

Abstract

Background: Amidst this global pandemic, the impact on accessing care and support for cancer survivors in Australia is uncertain and unknown. The purpose of the current study is to explore the impact that COVID-19 had on Australian rural/regional cancer survivors and their ability to access health services, treatment, and supportive care during this pandemic.
Methods: Cancer survivors (n = 66) completed an online survey regarding the impact of COVID-19 on their access to medical and support services.
Results: Findings indicated that COVID-19 had a significant impact on the lives of cancer survivors with the biggest challenges being reduced social support and the inability to see their health care providers. Findings also revealed that older participants reported greater impact and distress due to COVID-19.Conclusions: In order to ensure that the health and support needs of cancer survivors are not negatively impacted, providers of psychosocial support may need to make strategic changes in the provision of access to health and support services.

Entities:  

Keywords:  Australia; COVID; assess to services; cancer; distress; survivorship

Mesh:

Year:  2021        PMID: 33787464      PMCID: PMC8689679          DOI: 10.1080/07347332.2021.1904086

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  8 in total

1.  Older People Living Well Beyond Cancer: The Relationship Between Emotional Support and Quality of Life.

Authors:  Patty Doran; Sorrel Burden; Nick Shryane
Journal:  J Aging Health       Date:  2018-09-10

Review 2.  Quality of life in "chronic" cancer survivors: a meta-analysis.

Authors:  Jenny Firkins; Lissi Hansen; Martha Driessnack; Nathan Dieckmann
Journal:  J Cancer Surviv       Date:  2020-03-11       Impact factor: 4.442

3.  Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: Findings from a nationally representative sample.

Authors:  Sarah C Reed; Janice F Bell; Diana L Miglioretti; Larissa Nekhlyudov; Nathan Fairman; Jill G Joseph
Journal:  J Psychosoc Oncol       Date:  2019-09-11

4.  Older people and COVID-19: Isolation, risk and ageism.

Authors:  Joanne Brooke; Debra Jackson
Journal:  J Clin Nurs       Date:  2020-05-05       Impact factor: 3.036

5.  Beyond treatment - Psychosocial and behavioural issues in cancer survivorship research and practice.

Authors:  Neil K Aaronson; Vittorio Mattioli; Ollie Minton; Joachim Weis; Christoffer Johansen; Susanne O Dalton; Irma M Verdonck-de Leeuw; Kevin D Stein; Catherine M Alfano; Anja Mehnert; Angela de Boer; Lonneke V van de Poll-Franse
Journal:  EJC Suppl       Date:  2014-05-29

6.  Addressing the needs of cancer survivors during the COVID-19 pandemic.

Authors:  Larissa Nekhlyudov; Saskia Duijts; Shawna V Hudson; Jennifer M Jones; Justin Keogh; Brad Love; Maryam Lustberg; Katherine Clegg Smith; Amye Tevaarwerk; Xinhua Yu; Michael Feuerstein
Journal:  J Cancer Surviv       Date:  2020-10       Impact factor: 4.442

Review 7.  The psychosocial determinants of quality of life in breast cancer survivors: a scoping review.

Authors:  Michael G Culbertson; Kathleen Bennett; Catherine M Kelly; Linda Sharp; Caitriona Cahir
Journal:  BMC Cancer       Date:  2020-10-02       Impact factor: 4.430

8.  Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.

Authors:  Elizabeth Lerner Papautsky; Tamara Hamlish
Journal:  Breast Cancer Res Treat       Date:  2020-08-09       Impact factor: 4.624

  8 in total
  1 in total

1.  Perspectives of cancer patients during the COVID-19 outbreak in Israel: The long-term implications on support and well-being in an exploratory qualitative study.

Authors:  Osnat Bashkin; Roni Nahmias; Sarah Attar; Reut Moshe; Noam Asna
Journal:  Eur J Cancer Care (Engl)       Date:  2022-07-15       Impact factor: 2.328

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.